Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:6465
TSE:6465Machinery

Does Hoshizaki’s Higher Year End Dividend Signal a Strategic Shift in Capital Allocation (TSE:6465)?

In a board meeting held on December 16, 2025, Hoshizaki Corporation raised its year-end dividend projection for the fiscal year ending December 2025 from ¥55 to ¥65 per share. This move underlines Hoshizaki’s focus on steady profit distribution and a payout ratio of at least 40% while still funding growth investments and maintaining capital efficiency. We’ll now examine how this higher dividend commitment shapes Hoshizaki’s investment narrative and what it may signal about capital...
TSE:6367
TSE:6367Building

Assessing Daikin Industries (TSE:6367) Valuation After Its Strategic European Heat Pump Expansion With Copeland

Daikin IndustriesLtd (TSE:6367) is pushing deeper into Europe through an expanded joint venture with Copeland, targeting the fast growing residential heat pump market as the region leans harder into its energy transition. See our latest analysis for Daikin IndustriesLtd. Even with this heat pump push in Europe, Daikin’s share price return has only climbed modestly over the year, though a solid 90 day share price return suggests momentum is quietly building as investors warm to its long term...
NYSE:CBL
NYSE:CBLRetail REITs

The Bull Case For CBL & Associates Properties (CBL) Could Change Following New Buyback And Refinancing Moves

Earlier in 2025, CBL & Associates Properties announced a new US$25 million stock repurchase program through November 2026 and closed nearly US$158 million in financing across three transactions, including a lower-rate US$43 million loan used to retire existing debt. These moves highlight the company’s focus on capital allocation and refinancing to potentially strengthen its balance sheet and operational flexibility. Next, we’ll examine how the new US$25 million buyback program could...
TSE:4503
TSE:4503Pharmaceuticals

Is Astellas Pharma Still Attractive After a 43% Surge and DCF Upside Signals?

Wondering if Astellas Pharma’s strong run still offers value, or if you might be late to the party? This breakdown will help you decide whether the current price still makes sense. The stock has climbed 2.2% over the last week, 9.7% in the past month, and is up 37.5% year to date and 43.0% over the last year, so it is firmly on many investors’ radar. Recent headlines have focused on Astellas expanding its pipeline through strategic partnerships and regulatory milestones for key therapies,...
NYSE:LCII
NYSE:LCIIAuto Components

Earnings Estimate Upgrades Could Be A Game Changer For LCI Industries (LCII)

Recently, LCI Industries received a top Zacks Rank of #1 as analysts raised full-year earnings estimates by 12.8% over the past 90 days, supported by a year-to-date performance that has outpaced the broader Auto-Tires-Trucks sector. This upgrade builds on LCI Industries' consistent record of beating earnings expectations and valuation metrics that many investors view as attractive for value-focused exposure within auto components. With analyst earnings estimates moving higher and reinforcing...
NYSE:COTY
NYSE:COTYPersonal Products

Is Coty a Value Opportunity After a 53% Share Price Slide?

If you are wondering whether Coty is a beaten down value opportunity or a value trap at today’s price, this article will walk you through what the numbers really say. The stock has barely budged in the short term, up 1.2% over the past week and just 0.3% over the last month. However, zooming out shows a much rougher ride, with the share price down 52.5% year to date and 53.7% over the last year. Those steep longer term declines reflect a mix of investor concerns around the pace of Coty’s...
SEHK:2142
SEHK:2142Biotechs

HBM Holdings (SEHK:2142): Valuation Check After Bristol Myers Squibb Collaboration Validates Growth Prospects

HBM Holdings (SEHK:2142) just landed a multi year global collaboration and license deal with Bristol Myers Squibb, tying its antibody discovery platform to potentially more than $1.1 billion in future payments. See our latest analysis for HBM Holdings. The market has already started to reprice that validation, with a 1 day share price return of 6.6 percent pushing HBM Holdings to HK$13.34. Its roughly 574 percent year to date share price return and nearly 896 percent 1 year total shareholder...
ASX:SGR
ASX:SGRHospitality

Star Entertainment Group (ASX:SGR): Valuation Check After Major Boardroom Overhaul and Leadership Reshuffle

Star Entertainment Group (ASX:SGR) has kicked off a fresh chapter after a packed December board meeting reshaped its leadership, with Bruce Mathieson Jnr moving from chairman to CEO and Soo Kim taking the chair. See our latest analysis for Star Entertainment Group. The leadership shake up and Bally's backed recapitalisation have given the stock fresh momentum, with a 30 day share price return of 52.94% contrasting sharply with a still deeply negative five year total shareholder return of...
NasdaqGS:CHA
NasdaqGS:CHAHospitality

Is Chagee Holdings (CHA) Using ESG And Health Branding To Build A Defensible Tea Empire?

In 2025, Chagee Holdings released its inaugural 2024 Sustainability Report and continued expanding across Asia Pacific, now operating over 7,338 tea houses in markets including Indonesia, the Philippines, Vietnam, Singapore, Malaysia, and Thailand. By pairing ESG-focused initiatives with health certifications and culturally tailored product innovation, the company is positioning its modern tea brand to appeal to both socially conscious and health-oriented consumers across the region. We’ll...